Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 18, 2007
Diabetes 56:2135-2141, 2007
DOI: 10.2337/db06-1017
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Erratum (v56,p2650)
Right arrow All Versions of this Article:
db06-1017v1
56/8/2135    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallagher, C. J.
Right arrow Articles by Sale, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallagher, C. J.
Right arrow Articles by Sale, M. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Association of the Estrogen Receptor-{alpha} Gene With the Metabolic Syndrome and Its Component Traits in African-American Families

The Insulin Resistance Atherosclerosis Family Study

Carla J. Gallagher1,2,3, Carl D. Langefeld4, Candace J. Gordon2, Joel K. Campbell4, Josyf C. Mychalecky2,4,5,6,7, Michael Bryer-Ash8, Stephen S. Rich6,7, Donald W. Bowden1,2,5, and Michèle M. Sale2,5,6,9,10

1 Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina
2 Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina
3 Department of Health Evaluation Sciences, Penn State College of Medicine, Hershey, Pennsylvania
4 Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
5 Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina
6 Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia
7 Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia
8 Division of Endocrinology, Diabetes and Metabolism, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
9 Department of Medicine, University of Virginia, Charlottesville, Virginia
10 Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia

Address correspondence and reprint requests to Michèle M. Sale, PhD, Center for Public Health Genomics, University of Virginia, P.O. Box 800717, Charlottesville, VA 22908. E-mail: msale{at}virginia.edu

Abbreviations: CVD, cardivascular disease; ESR1, estrogen receptor-{alpha}; FPG, fasting plasma glucose; GEE, generalized estimating equation; PDT, pedigree disequilibrium test; SAT, subcutaneous adipose tissue; SNP, single nucleotide polymorphism; QPDT quantitative PDT; VAT, visceral adipose tissue

OBJECTIVE— We previously detected an association between a region of the estrogen receptor-{alpha} (ESR1) gene and type 2 diabetes in an African-American case-control study; thus, we investigated this region for associations with the metabolic syndrome and its component traits in African-American families from the Insulin Resistance Atherosclerosis Family Study.

RESEARCH DESIGN AND METHODS— A total of 17 single nucleotide polymorphisms (SNPs) from a contiguous 41-kb intron 1–intron 2 region of the ESR1 gene were genotyped in 548 individuals from 42 African-American pedigrees. Generalized estimating equations were computed using a sandwich estimator of the variance and exchangeable correlation to account for familial correlation.

RESULTS— Significant associations were detected between ESR1 SNPs and the metabolic syndrome (P = 0.005 to P = 0.029), type 2 diabetes (P = 0.001), insulin sensitivity (P = 0.0005 to P = 0.023), fasting insulin (P = 0.022 to P = 0.033), triglycerides (P = 0.021), LDL (P = 0.016 to P = 0.034), cholesterol (P = 0.046), BMI (P = 0.016 to P = 0.035), waist circumference (P = 0.012 to P = 0.023), and subcutaneous adipose tissue area (P = 0.016).

CONCLUSIONS— It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J.-Y. Deng, P.-S. Hsieh, J.-P. Huang, L.-S. Lu, and L.-M. Hung
Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways
Diabetes, July 1, 2008; 57(7): 1814 - 1823.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.